| Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study. | |
| | |
MedLine Citation:
|
PMID: 19773393 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
CONTEXT: Although recombinant human TSH (rhTSH) is widely used in differentiated thyroid cancer (DTC) to aid diagnostic follow-up procedures and radioiodine thyroid remnant ablation, almost all clinical investigation was in adults. OBJECTIVE: The aim of this study was to characterize rhTSH clinical safety and peak TSH response in DTC patients 18 yr old or younger. DESIGN AND SETTING: We conducted a retrospective study involving 23 tertiary referral centers in 12 European, Asian, and Oceanian countries. PATIENTS: One hundred DTC patients (69% female, 31% male, 84% papillary, 61% N1, 18% M1) ages 4.9-18 yr at first rhTSH administration were studied. INTERVENTIONS: A total of 181 rhTSH courses were administered (range, one to eight per patient; 42% of patients received two or more courses), 92% using the approved adult regimen (one 0.9 mg im injection daily on two consecutive days), 34% including thyroid hormone withdrawal for less than 7 d ("mini-THW"). MAIN OUTCOME MEASURES: Clinical adverse event (AE) incidence, type, and severity, and peak post-rhTSH serum TSH concentrations were assessed. RESULTS: No clinical AEs occurred in 88% of rhTSH courses. Most common clinical AEs were nausea (5% of courses) and vomiting (3%). Multiple or severe AEs were rare (0.6% and 2.8% of courses, respectively); serious AEs were absent. Peak TSH concentration post-rhTSH exceeded 25 mU/liter in approximately 98% of courses. In logistic regression analyses, the rhTSH regimen, "mini-THW," peak TSH concentration, body mass index (BMI), or peak TSH concentration/unit of BMI were not associated with clinical AE occurrence. In analyses of covariance, higher BMI was associated with lower peak TSH concentrations. CONCLUSIONS: rhTSH was clinically well tolerated in pediatric DTC patients although courses preponderantly comprised the adult regimen, and repeated courses were frequent. Both the adult and reduced-dose regimens almost always sufficiently elevate TSH in children and adolescents. |
| | |
Authors:
|
Markus Luster; Daria Handkiewicz-Junak; Armando Grossi; Margaret Zacharin; David Taïeb; Ofelia Cruz; Anne Hitzel; Juan Antonio Vallejo Casas; Uwe Mäder; Massimo E Dottorini; |
Related Documents
:
|
3186463 - Factors predicting hypothyroidism in long-term follow-up after 131i therapy. 2510123 - Euthyroid infiltrative ophthalmopathy: clinical-immunological characteristics. 18600143 - Myelographic evaluation of cervical spondylosis: patient tolerance and complications. |
Publication Detail:
|
Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't Date: 2009-09-22 |
Journal Detail:
|
Title: The Journal of clinical endocrinology and metabolism Volume: 94 ISSN: 1945-7197 ISO Abbreviation: J. Clin. Endocrinol. Metab. Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2009-10-07 Completed Date: 2009-10-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375362 Medline TA: J Clin Endocrinol Metab Country: United States |
Other Details:
|
Languages: eng Pagination: 3948-53 Citation Subset: AIM; IM |
Affiliation:
|
Department of Nuclear Medicine, University of Würzburg, 97080 Würzburg, Germany. Markus.Luster@uniklinik-ulm.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Oral Adolescent Analysis of Variance Asia Carcinoma* / blood, surgery Child Child, Preschool Europe Female Humans Hypothyroidism / drug therapy, etiology, prevention & control Logistic Models Male Multivariate Analysis Oceania Recombinant Proteins / therapeutic use Research Design Retrospective Studies Thyroid Neoplasms* / blood, radiotherapy, surgery Thyroidectomy / adverse effects Thyrotropin / administration & dosage, adverse effects, blood*, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Recombinant Proteins; 9002-71-5/Thyrotropin |
| Investigator | |
Investigator/Affiliation:
|
Marcus Schneider-Ludorff / ; Frederik A Verburg / ; Christoph Reiners / ; Peter Lind / ; Isabel Igerc / ; Susanne Kohlfürst / ; Diego De Palma / ; Lutz Freudenberg / ; Andreas Bockisch / ; Giovanni Lupoli / ; Gelsy Arianna Lupoli / ; Annalisa Panico / ; Jan Tennvall / ; Claire Bournaud / ; Renzo Mazzarotto / ; Federica Vianello / ; Klaus P Kaiser / ; Luis Matos Lima / ; Thorsten Petrich / ; Lutz Bischoff / ; Wolfram Knapp / ; Sa'ad El-Deen Mahwood / ; Iman al-Shammeri / ; Amar Naoun / ; Marie-Elisabeth Toubert / ; Annick Van den Bruel / ; Barbara Jarzab / ; Kornelia Hasse-Lazar / ; Sylwia Szpak-Ulczok / ; Maria Carmen Garganese / ; Willie F E Lau / ; G Wheeler / ; V Johnston / ; R J Hicks / ; Peter MacCallum / ; K Waters / ; Olivier Mundler / ; José M Latre Romero / ; Luisa M Mena Bares / ; Robert J Marlowe / |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sequence Divergence of Heat Shock Genes within and among 3 Oncorhynchids.
Next Document: Thyrotropin secretion profiles are not different in men and women.